XCHC to Launch its New Website at 11:00am PDT Today, Critical Ailment Information, Patient Tracking Resources, Cannabinoid Research Platforms, and Patient-to-Patient Information Exchange
DALLAS, May 15, 2013 /PRNewswire/ -- X-Change Corp. (NASDAQ OTC: XCHC), a U.S. Company specializing in cannabinoid formulation-based health solutions through its Phytiva brand product lines is excited to announce at 11:00am PDT the launch of its new website at www.phytiva.com. The team has been working to create a website that provides self-medicated cannabinoid patients with an online center for information about cannabinoid solutions for critical ailments, as well as patient resources and support. The website takes a serious approach to the epidemics that humanity is facing and the need for novel, successful solutions.
The website features a new section called the "Patient Resource Center". Patients, caregivers, doctors, and others can visit this area of the website to share their experiences with cannabinoid treatments and track their progress. With this new technology, registered medical marijuana patients will be able to join a secure, web-based, information-sharing community. Using a username and password, patients will login and record their daily progress, while they self-administer their cannabinoid treatments. Patients will also have the ability to add pictures or videos to show the progress of the treatment.
The website will provide a pre-registration for the Patient Resource Center while the center is under development. The aim is to provide a resource platform for information sharing, totally controlled by the patient that will generate cannabinoid health to another level of quality and authenticity. The section also features the stories of four patients who have opted to self-administer cannabinoid-based oils to their squamous and basal cell carcinomas, with picture evidence of the apparent eradication thereof.
In the "Research & Education" section of the new website, visitors to the site can read about anecdotal and scientific cannabinoid treatments and how they affect certain ailments. The Company has identified 20 critical ailments that respond positively to cannabinoid solutions. This section also covers the growing legal social usage of cannabinoids, a market that the Company aims to enter with its products. In addition, the website features information about the ingredients of Phytiva's products to educate consumers on the positive properties of cannabinoids and other natural substances, such as Aloe Vera and Vitamin E.
In the future, the website will also feature an online store for the over the counter nutraceutical and cosmeceutical product lines. As always, recent press releases and breaking news are still viewable on the site, as well as information for investors and profiles of the management team's members. The website's design has been upgraded for a more interesting and effective viewing experience.
About Phytiva Brand Product Lines
Phytiva expects to develop and launch various innovative product lines. The first is the Phytiva Brand European Line, which is an inventive line that is a hybrid of a proven, existing product line that has been well-managed and conservatively-run for over a decade with a cannabinoid based product line, utilizing the unique and potent benefits of cannabinoids. Phytiva's revolutionary formulations target not just the symptom, but also the cause. Cannabinoids and their sources constitute an ideal base for therapeutic solutions and have been utilized for centuries in skin and other remedies for human ailments.
About The X-Change Corporation
X-Change Corp. is a U.S. Company specializing in cannabinoid based extracts and products that target medical cannabis, nutraceutical, cosmeceutical, and social usage solutions through multiple Phytiva Brand product lines, products, and services. These new Phytiva lines will be launched with cannabinoid based formulations through the launching of a combination of retail and wholesale products, medical cannabis dispensaries, cannabis research in clinics and laboratories, and other legal state and foreign grow operations, on a jurisdiction by jurisdiction approved basis.
Forward Looking Statements
This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based drugs. X-Change Corp. does not undertake any duty nor does it intend to update the results of these forward-looking statements.
X-Change Corp.
President & CEO
Robert Kane
1.866.326.5595
SOURCE X-Change Corp.
Share this article